Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,018.80
(
-1.13%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.24
(
1.02%
)
Bitcoin
68,433.49
(
0.88%
)
News Focus
News Focus
Post# of 30495
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 12459

Wednesday, 04/20/2016 2:29:37 PM

Wednesday, April 20, 2016 2:29:37 PM

Post# of 30495
ABT raised 2016 non-GAAP EPS guidance to $2.14-2.24 (from old range of $2.10-2.20) based on a solid 1Q16, especially in emerging markets:

http://finance.yahoo.com/news/abbott-reports-first-quarter-2016-114500807.html

Sales of branded-generic drugs in India (ABT’s largest market) were +11% YoY in constant currency.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today